2020

Potential drug treatments for telomere diseases

April 24, 2020

HSCI researchers have identified potential drugs to treat telomere diseases such as dyskeratosis congenita (DC), in which cells age prematurely. The researchers tested over 100,000 compounds on patient stem cells, and identified several drugs that restored  the cells’ telomeres — the protective caps on the ends of chromosomes that regulate how cells age.

“We envision these to be a new class of oral medicines that target stem cells throughout the body,” said Suneet Agarwal, an HSCI principal faculty member at Boston Children’s Hospital. “We expect restoring telomeres in...

Read more about Potential drug treatments for telomere diseases

Call for Proposals: HSCI Skin Program 2020 Incubator Awards

March 23, 2020

Award amount

$50,000 per project per year for one year

Posted Date

Monday, February 10, 2020 | Updated March 23, 2020

Deadline for application

Friday, May 1, 2020

Anticipated award date

Tuesday, September 1, 2020* (*disbursement of funds may be delayed by COVID-19-related disruptions)

 

The mission of the Harvard Stem Cell Institute is to find cures for human diseases. Through collaborative research in the fields of stem cell and regenerative biology, we seek to:

... Read more about Call for Proposals: HSCI Skin Program 2020 Incubator Awards

Pages